NEW YORK and LONDON, June 13, 2012 /PRNewswire/ — Paulson & Co. Inc. (Bloomberg: 573991Z), the beneficial owner of 5,040,000 shares of Rhoen Klinikum AG which it controls on behalf of funds and accounts for which it serves as investment manager, today announced that it sees the value in the potential deal between Rhoen Klinikum AG and Fresenius SE & Co KGAA, and intends to tender all its Rhoen Klinikum AG shares, currently owned or purchased before the tender deadline.

Paulson & Co. is an investment management firm that specializes in merger arbitrage, event-driven and distressed investing. Paulson has approximately US$24 billion in assets under management and has offices in New York, London and Hong Kong.